Skip to main content

MoneyWorks4Me

Marksans Pharma informs about board meeting

08 May 2025 Evaluate
Marksans Pharma has informed that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025, to consider and approve the Audited Financial Results of the Company (both Standalone and Consolidated) for the Quarter and Year ended March 31, 2025; To consider recommendation of dividend on the equity shares for the financial year 2024-25, if any.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..